- Congenital Nephrogenic Diabetes Insipidus with Bilateal Hydronephrosis: Indomethacin in Treatment of Nephrogenic Diabetes Insipidus
-
Sohn YM, Lee C, Kim PK, Yun DJ
- KMID: 692904
- Yonsei Med J.
- 1980 Dec;21(2):116-122.
- doi: 10.3349/ymj.1980.21.2.116
A 13-year-old boy was diagnosed as having primary nephrogenic diabetes insipidus, and symptoms developed at 3 years of age. Subsequently he developed bilateral hydronephrosis and a neurogenic bladder. His pedigree... -
- CITED
-
- Close
- SHARE
-
- Close
- Delayed redo pyeloplasty fails to recover lost renal function after failed pyeloplasty: Early sonographic changes that correlate with a loss of differential renal function
-
Chung DY, Hong CH, Im YJ, Lee YS, Kim SW, Han SW
- KMID: 2133281
- Korean J Urol.
- 2015 Feb;56(2):157-163.
- doi: 10.4111/kju.2015.56.2.157
PURPOSE: To evaluate changes in differential renal function (DRF), as a functional outcome, in children who underwent redo pyeloplasty for management of failed pyeloplasty and to examine the factors that... -
- CITED
-
- Close
- SHARE
-
- Close
- Foreign Body Granulomas Simulating Recurrent Tumors in Patients Following Colorectal Surgery for Carcinoma: a Report of Two Cases
-
Kim SW, Shin HC, Kim IY, Baek MJ, Cho HD
- KMID: 1779461
- Korean J Radiol.
- 2009 Jun;10(3):313-318.
- doi: 10.3348/kjr.2009.10.3.313
We report here two cases of foreign body granulomas that arose from the pelvic wall and liver, respectively, and simulated recurrent colorectal carcinomas in patients with a history of surgery.... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative ureteral obstruction after endoscopic treatment for vesicoureteral reflux
-
Chung JM, Park CS, Lee SD
- KMID: 2160651
- Korean J Urol.
- 2015 Jul;56(7):533-539.
- doi: 10.4111/kju.2015.56.7.533
PURPOSE: We undertook this study to evaluate the incidence, risk factors, management, and outcome of postoperative ureteral obstruction after endoscopic treatment for vesicoureteral reflux (VUR). MATERIALS AND METHODS: Ninety patients undergoing... -
- CITED
-
- Close
- SHARE
-
- Close
